Literature DB >> 25815270

Diagnostic dilemma of coagulation problems in an HIV-positive patient with end-stage liver disease undergoing liver transplantation.

Ali Abdullah1, Ibtesam A Hilmi1, Raymond Planinsic1.   

Abstract

Human immunodeficiency virus (HIV) may result in devastating multi-organ complications, including cirrhosis. Consequently, liver transplantation is often required for these patients. We report a case of a 43-year-old female with cryptogenic cirrhosis and HIV on highly active antiretroviral therapy, presenting for non-related living donor liver transplantation. The intra-operative course was complicated by hepatic artery and portal vein thrombosis, requiring thrombectomy. On postoperative day-3, the patient required re-transplantation with a cadaveric donor organ due to primary graft failure.

Entities:  

Keywords:  Highly active antiretroviral therapy; Human immunodeficiency virus; Hypercoagulation; Liver transplant

Year:  2015        PMID: 25815270      PMCID: PMC4371160          DOI: 10.5500/wjt.v5.i1.34

Source DB:  PubMed          Journal:  World J Transplant        ISSN: 2220-3230


  11 in total

Review 1.  Platelet and coagulation defects associated with HIV-1-infection.

Authors:  Simon Karpatkin; Michael Nardi; David Green
Journal:  Thromb Haemost       Date:  2002-09       Impact factor: 5.249

2.  Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy.

Authors:  W M Lijfering; M K Ten Kate; H G Sprenger; J van der Meer
Journal:  J Thromb Haemost       Date:  2006-09       Impact factor: 5.824

Review 3.  Role of inflammation in HIV-1 disease progression and prognosis.

Authors:  Hayley Ipp; Annalise E Zemlin; Rajiv T Erasmus; Richard H Glashoff
Journal:  Crit Rev Clin Lab Sci       Date:  2014-01-30       Impact factor: 6.250

4.  Serum concentrations of antiphospholipid and anticardiolipin antibodies are higher in HIV-infected women.

Authors:  Alireza Abdollahi; Afsaneh Morteza
Journal:  Rheumatol Int       Date:  2011-03-30       Impact factor: 2.631

Review 5.  Heparin-induced thrombocytopenia (an overview).

Authors:  H L Daneschvar; H Daw
Journal:  Int J Clin Pract       Date:  2006-07-12       Impact factor: 2.503

6.  Increased erythrocyte glutathione peroxidase activity and serum tumor necrosis factor-alpha in HIV-infected patients: relationship to on-going prothrombotic state.

Authors:  R Trotti; M Rondanelli; A Anesi; E Gabanti; R Brustia; L Minoli
Journal:  J Hematother Stem Cell Res       Date:  2002-04

7.  Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series.

Authors:  Michael C Jacobson; Bruce J Dezube; David M Aboulafia
Journal:  Clin Infect Dis       Date:  2004-09-27       Impact factor: 9.079

8.  Study of vascular reactivity in HIV patients whether or not receiving protease inhibitor.

Authors:  Hamilton Nenrod Pereira Teixeira; Evandro Tinoco Mesquita; Mário Luiz Ribeiro; Anna Ricordi Bazin; Cláudio Tinoco Mesquita; Manuel Pereira Teixeira; Rafael da Cunha Pellegrini; Antonio Claudio Lucas da Nóbrega
Journal:  Arq Bras Cardiol       Date:  2009-10       Impact factor: 2.000

Review 9.  HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies.

Authors:  E Hulten; J Mitchell; J Scally; B Gibbs; T C Villines
Journal:  Heart       Date:  2009-07-23       Impact factor: 5.994

10.  HIV infection is a risk factor for venous thromboembolism.

Authors:  A Sinan Copur; Peter R Smith; Victor Gomez; Michael Bergman; Peter Homel
Journal:  AIDS Patient Care STDS       Date:  2002-05       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.